PDF(Pubmed)
Abstract：
This epidemiological study described changes in the estimated prevalence of current pharmacological and/or psychotherapy-based treatment utilization among college students with depression only, anxiety only, or comorbid depression & anxiety.
A sample of 190,500 weighted responses was collected through the 2013-2019 Healthy Minds Study questionnaires. Annual prevalence estimates of depression only, anxiety only, or comorbid depression & anxiety were computed. Current use of therapy, pharmacological services, or dual treatment among students with depression and/or anxiety were examined via descriptive statistics.
Estimated prevalence of college students who screened positive for depression only, anxiety only, and comorbid depression & anxiety escalated from 2013 to 2018-2019. When assessed individually, rates of currently using any psychiatric medication, participating in therapy, and engaging in concurrent medication & therapy services significantly rose among students with depression and/or anxiety. However, temporal trends in the current use of specific classes of psychiatric medications among young adults with depression only, anxiety only, or comorbid depression & anxiety differed by medication class.
This study was unable to assess psychiatric prescribing practices, depression or anxiety diagnoses, and prior mental health treatment.
An increasing proportion of college students are reporting depression and/or anxiety symptoms as well as pharmacological and/or psychotherapy service utilization when comparing rates from 2013 to 2018-19. Although this may indicate increasing acceptability to disclose and seek treatment for problematic symptomology, continued surveillance of college populations is needed to identify students at risk for adverse psychiatric health outcomes, especially during the coronavirus disease 2019 pandemic.
A sample of 190,500 weighted responses was collected through the 2013-2019 Healthy Minds Study questionnaires. Annual prevalence estimates of depression only, anxiety only, or comorbid depression & anxiety were computed. Current use of therapy, pharmacological services, or dual treatment among students with depression and/or anxiety were examined via descriptive statistics.
Estimated prevalence of college students who screened positive for depression only, anxiety only, and comorbid depression & anxiety escalated from 2013 to 2018-2019. When assessed individually, rates of currently using any psychiatric medication, participating in therapy, and engaging in concurrent medication & therapy services significantly rose among students with depression and/or anxiety. However, temporal trends in the current use of specific classes of psychiatric medications among young adults with depression only, anxiety only, or comorbid depression & anxiety differed by medication class.
This study was unable to assess psychiatric prescribing practices, depression or anxiety diagnoses, and prior mental health treatment.
An increasing proportion of college students are reporting depression and/or anxiety symptoms as well as pharmacological and/or psychotherapy service utilization when comparing rates from 2013 to 2018-19. Although this may indicate increasing acceptability to disclose and seek treatment for problematic symptomology, continued surveillance of college populations is needed to identify students at risk for adverse psychiatric health outcomes, especially during the coronavirus disease 2019 pandemic.
摘要：
这项流行病学研究描述了仅在患有抑郁症的大学生中，当前基于药物和/或心理治疗的治疗利用的估计患病率的变化。只有焦虑，或并存的抑郁和焦虑。
通过2013-2019年健康思想研究问卷收集了190,500个加权响应的样本。仅对抑郁症的年度患病率估计，只有焦虑，或共病抑郁和焦虑被计算。目前使用的疗法，药理服务，或双重治疗的学生抑郁和/或焦虑通过描述性统计进行了检查。
仅抑郁症筛查呈阳性的大学生的估计患病率，只有焦虑，从2013年到2018-2019年，抑郁和焦虑共病升级。当单独评估时，目前使用任何精神病药物的比率，参与治疗,在患有抑郁症和/或焦虑症的学生中，同时从事药物和治疗服务的人数显着增加。然而,目前仅在患有抑郁症的年轻人中使用特定类别的精神病药物的时间趋势，只有焦虑，或并存的抑郁和焦虑因药物类别而异。
这项研究无法评估精神病处方的做法，抑郁症或焦虑症的诊断，和之前的心理健康治疗。
在比较2013年至2018-19年的比率时，越来越多的大学生报告抑郁和/或焦虑症状以及药物和/或心理治疗服务利用率。尽管这可能表明公开和寻求治疗有问题的症状的可接受性增加，需要对大学人群进行持续监测，以确定有不良精神健康结果风险的学生，特别是在2019年冠状病毒疾病大流行期间。
通过2013-2019年健康思想研究问卷收集了190,500个加权响应的样本。仅对抑郁症的年度患病率估计，只有焦虑，或共病抑郁和焦虑被计算。目前使用的疗法，药理服务，或双重治疗的学生抑郁和/或焦虑通过描述性统计进行了检查。
仅抑郁症筛查呈阳性的大学生的估计患病率，只有焦虑，从2013年到2018-2019年，抑郁和焦虑共病升级。当单独评估时，目前使用任何精神病药物的比率，参与治疗,在患有抑郁症和/或焦虑症的学生中，同时从事药物和治疗服务的人数显着增加。然而,目前仅在患有抑郁症的年轻人中使用特定类别的精神病药物的时间趋势，只有焦虑，或并存的抑郁和焦虑因药物类别而异。
这项研究无法评估精神病处方的做法，抑郁症或焦虑症的诊断，和之前的心理健康治疗。
在比较2013年至2018-19年的比率时，越来越多的大学生报告抑郁和/或焦虑症状以及药物和/或心理治疗服务利用率。尽管这可能表明公开和寻求治疗有问题的症状的可接受性增加，需要对大学人群进行持续监测，以确定有不良精神健康结果风险的学生，特别是在2019年冠状病毒疾病大流行期间。
